File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Seminoma of normally-descended and cryptorchid testis

TitleSeminoma of normally-descended and cryptorchid testis
Authors
Keywordscryptorchid testis
normally-descended testis
Seminoma
Issue Date1990
PublisherWB Saunders Co Ltd. The Journal's web site is located at http://www.elsevier.com/locate/ejso
Citation
European Journal Of Surgical Oncology, 1990, v. 16 n. 1, p. 33-36 How to Cite?
AbstractThe records of 40 patients with seminoma of testis were reviewed; nine had cryptorchidism. The incidence of cryptorchidism among the 36 Chinese patients was 22% (8/36). All Stage I and four Stage II patients were treated by orchidectomy followed by radiotherapy of 30 Gy or more to the pelvic and para-aortic lymphatics, while another seven Stage II patients received pelvic and para-aortic lymphatics plus mediastinal irradiation. For patients with normally-descended testis, the 2-year survival for Stage I was 94% and Stage II, with small and clinically unpalpable nodal metastases, 86%. For patients with Stage I and II seminoma arising from cryptorchid testis, comparable survival can be achieved by giving similar doses of radiation and adjusting the size of the para-aortic and pelvic radiation fields to cover the known extent of the disease. The prognosis of patients with seminoma arising from cryptorchid testis depends more on the stage and extent of disease than the status of cryptorchid testis. Painful groin mass or abdominal pain were the presenting symptoms in more than half of the patients with cryptorchid testes. The changed symptomatology in this group of patients can result in diagnosis delay.
Persistent Identifierhttp://hdl.handle.net/10722/147850
ISSN
2021 Impact Factor: 4.037
2020 SCImago Journal Rankings: 1.395
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorSham, JSTen_US
dc.contributor.authorChoy, Den_US
dc.contributor.authorChan, KWen_US
dc.contributor.authorChoi, PHKen_US
dc.date.accessioned2012-05-29T06:09:33Z-
dc.date.available2012-05-29T06:09:33Z-
dc.date.issued1990en_US
dc.identifier.citationEuropean Journal Of Surgical Oncology, 1990, v. 16 n. 1, p. 33-36en_US
dc.identifier.issn0748-7983en_US
dc.identifier.urihttp://hdl.handle.net/10722/147850-
dc.description.abstractThe records of 40 patients with seminoma of testis were reviewed; nine had cryptorchidism. The incidence of cryptorchidism among the 36 Chinese patients was 22% (8/36). All Stage I and four Stage II patients were treated by orchidectomy followed by radiotherapy of 30 Gy or more to the pelvic and para-aortic lymphatics, while another seven Stage II patients received pelvic and para-aortic lymphatics plus mediastinal irradiation. For patients with normally-descended testis, the 2-year survival for Stage I was 94% and Stage II, with small and clinically unpalpable nodal metastases, 86%. For patients with Stage I and II seminoma arising from cryptorchid testis, comparable survival can be achieved by giving similar doses of radiation and adjusting the size of the para-aortic and pelvic radiation fields to cover the known extent of the disease. The prognosis of patients with seminoma arising from cryptorchid testis depends more on the stage and extent of disease than the status of cryptorchid testis. Painful groin mass or abdominal pain were the presenting symptoms in more than half of the patients with cryptorchid testes. The changed symptomatology in this group of patients can result in diagnosis delay.en_US
dc.languageengen_US
dc.publisherWB Saunders Co Ltd. The Journal's web site is located at http://www.elsevier.com/locate/ejsoen_US
dc.relation.ispartofEuropean Journal of Surgical Oncologyen_US
dc.subjectcryptorchid testis-
dc.subjectnormally-descended testis-
dc.subjectSeminoma-
dc.subject.meshAbdominal Painen_US
dc.subject.meshAdulten_US
dc.subject.meshCombined Modality Therapyen_US
dc.subject.meshCryptorchidism - Complicationsen_US
dc.subject.meshDysgerminoma - Complications - Pathology - Therapyen_US
dc.subject.meshFollow-Up Studiesen_US
dc.subject.meshHumansen_US
dc.subject.meshLymphatic Irradiation - Methodsen_US
dc.subject.meshMaleen_US
dc.subject.meshMiddle Ageden_US
dc.subject.meshNeoplasm Stagingen_US
dc.subject.meshOrchiectomyen_US
dc.subject.meshPrognosisen_US
dc.subject.meshRisk Factorsen_US
dc.subject.meshTesticular Neoplasms - Complications - Pathology - Therapyen_US
dc.titleSeminoma of normally-descended and cryptorchid testisen_US
dc.typeArticleen_US
dc.identifier.emailChan, KW:hrmtckw@hku.hken_US
dc.identifier.authorityChan, KW=rp00330en_US
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.pmid1968400-
dc.identifier.scopuseid_2-s2.0-0025008857en_US
dc.identifier.volume16en_US
dc.identifier.issue1en_US
dc.identifier.spage33en_US
dc.identifier.epage36en_US
dc.identifier.isiWOS:A1990CR39900008-
dc.publisher.placeUnited Kingdomen_US
dc.identifier.issnl0748-7983-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats